- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 177 results
Webinar
octubre 24, 2024
Real-World Data for Clinical Trials: Brand New FDA Expectations for Use of Real-World Evidence for Regulatory Decision-Making
Webinar
septiembre 19, 2024
Hot Topics in Behavioral Healthcare
Webinar
septiembre 18, 2024
Addressing Misinformation: Insights on Social Media and Influencer Marketing
Webinar
agosto 21, 2024
Managing New and Emerging Data Privacy and Security Risks for U.S. and EU Life Sciences Companies
Webinar
julio 18, 2024
Talk im Turm: Update on Regulation of Remuneration in Investment Firms
Webinar
julio 17, 2024
Government Attack on Three Fronts: Pharmaceutical and Medical Device Industries Face Continual Pricing Pressure
Webinar
julio 16, 2024
Healthcare Regulation in a Post-Chevron World: What the Supreme Court’s Decision in Loper Bright Means for Healthcare Providers
Webinar
julio 10, 2024
Key Legal Considerations Around Purchasing Assets in a Bankruptcy Proceeding: The Landscape, the Process, and What You Need to Know
Webinar
mayo 30, 2024
Recent Amendments to Rule 702: Watershed Moment or Small Tweaks?
Webinar
mayo 29, 2024
The Latest in CCM and RPM Healthcare Enforcement Trends
Webinar
mayo 8, 2024
Navigating Troubled Waters: Healthcare Transactions in a Time of Regulatory Scrutiny and Skepticism
Webinar
mayo 2, 2024
Client Briefing: FTC Final Rule on Non-Compete Agreements